Episode 83: How biotech VC works w/ health care journalist Maggie Fox, Vioxx and synthetic biology
Oct 10, 2019
23:46
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
STAT's Matthew Herper joins us to dig into the history of the infamous pain drug Vioxx and a new effort to bring it back as a rare disease treatment. Then, we discuss how the synthetic biology industry is growing up and getting corporate. Finally, health care journalist Maggie Fox dials in to explain her deep dive on venture capital in biotech.
The Readout Loud